Dana Maglio

478 total citations
20 papers, 385 citations indexed

About

Dana Maglio is a scholar working on Pharmacology, Epidemiology and Molecular Medicine. According to data from OpenAlex, Dana Maglio has authored 20 papers receiving a total of 385 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pharmacology, 14 papers in Epidemiology and 9 papers in Molecular Medicine. Recurrent topics in Dana Maglio's work include Antibiotics Pharmacokinetics and Efficacy (15 papers), Pneumonia and Respiratory Infections (11 papers) and Antibiotic Resistance in Bacteria (9 papers). Dana Maglio is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (15 papers), Pneumonia and Respiratory Infections (11 papers) and Antibiotic Resistance in Bacteria (9 papers). Dana Maglio collaborates with scholars based in United States and Russia. Dana Maglio's co-authors include David P. Nicolau, Charles H. Nightingale, Mary Anné Banevicius, Christina Sutherland, Joseph L. Kuti, Prachi K. Dandekar, C Andrew DeRyke, Blair Capitano, David P. Nicolau and Chinedum P. Babalola and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Journal of Antimicrobial Chemotherapy and International Journal of Antimicrobial Agents.

In The Last Decade

Dana Maglio

20 papers receiving 371 citations

Peers

Dana Maglio

PHARM

EPIDE

AMB

Jill Butterfield United States

Pornpan Koomanachai Thailand

Jessica Cottreau United States

Milva Ballardini Italy

J.R. Paño‐Pardo Spain

G. Poulakou Greece

Madiha Salim United States

Jufang Wu China

B. Schroeren-Boersch Germany

C. K. Johnson United States

Jill Butterfield United States

Dana Maglio

262 ×1.0

PHARM

120 ×0.6

163 ×0.9

EPIDE

58 ×0.8

AMB

156 ×2.2

Citations per year, relative to Dana Maglio Dana Maglio (= 1×) peers Jill Butterfield

Countries citing papers authored by Dana Maglio

Since Specialization

Citations

This map shows the geographic impact of Dana Maglio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dana Maglio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dana Maglio more than expected).

Fields of papers citing papers by Dana Maglio

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dana Maglio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dana Maglio. The network helps show where Dana Maglio may publish in the future.

Co-authorship network of co-authors of Dana Maglio

This figure shows the co-authorship network connecting the top 25 collaborators of Dana Maglio. A scholar is included among the top collaborators of Dana Maglio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dana Maglio. Dana Maglio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Maglio, Dana, Toral Patel, Mary Anné Banevicius, et al.. (2014). Pharmacodynamic profiling of modithromycin: Assessment in a pneumococcal murine pneumonia model. International Journal of Antimicrobial Agents. 43(6). 540–546. 2 indexed citations

Maglio, Dana. (2006). ▼Drotrecogin alfa (activated) for severe sepsis. Drug and Therapeutics Bulletin. 44(1). 5–8. 10 indexed citations

DeRyke, C Andrew, Dana Maglio, & David P. Nicolau. (2005). Defining the need for new antimicrobials: clinical and economic implications of resistance in the hospitalised patient. Expert Opinion on Pharmacotherapy. 6(6). 873–889. 19 indexed citations

Maglio, Dana, Joseph L. Kuti, & David P. Nicolau. (2005). Simulation of Antibiotic Pharmacodynamic Exposure for the Empiric Treatment of Nosocomial Bloodstream Infections: A Report from the OPTAMA Program. Clinical Therapeutics. 27(7). 1032–1042. 18 indexed citations

Lee, Su Young, et al.. (2005). Efficacy of pulsatile amoxicillin and clarithromycin dosing alone and in combination in a murine pneumococcal pneumonia model. Journal of Antimicrobial Chemotherapy. 56(3). 559–565. 5 indexed citations

Maglio, Dana & David P. Nicolau. (2004). The integration of pharmacokinetics and pathogen susceptibilitydata in the design of rational dosing regimens. Methods and Findings in Experimental and Clinical Pharmacology. 26(10). 781–781. 6 indexed citations

Maglio, Dana, Blair Capitano, Mary Anné Banevicius, et al.. (2004). Efficacy of clarithromycin against Streptococcus pneumoniae expressing mef(A)-mediated resistance. International Journal of Antimicrobial Agents. 23(5). 498–501. 7 indexed citations

Amsden, Guy W., et al.. (2004). Characterization of the Penetration of Garenoxacin into the Breast Milk of Lactating Women. The Journal of Clinical Pharmacology. 44(2). 188–192. 3 indexed citations

Maglio, Dana, et al.. (2004). Differential Efficacy of Clarithromycin in Lung versus Thigh Infection Models. Chemotherapy. 50(2). 63–66. 17 indexed citations

10.

Maglio, Dana, et al.. (2004). Macrolide resistance in Streptococcus pneumoniae: mechanisms, patterns, and clinical implications of resistance.. PubMed. 68(9). 571–6. 1 indexed citations

11.

Maglio, Dana, Mary Anné Banevicius, Christina Sutherland, et al.. (2004). Pharmacodynamic Profile of Ertapenem against Klebsiella pneumoniae and Escherichia coli in a Murine Thigh Model. Antimicrobial Agents and Chemotherapy. 49(1). 276–280. 22 indexed citations

12.

Maglio, Dana, et al.. (2004). Determination of the In Vivo Pharmacodynamic Profile of Cefepime against Extended-Spectrum-Beta-Lactamase-Producing Escherichia coli at Various Inocula. Antimicrobial Agents and Chemotherapy. 48(6). 1941–1947. 62 indexed citations

13.

Maglio, Dana, Charles H. Nightingale, & David P. Nicolau. (2003). Production and resolution of cantharidin-induced inflammatory blisters. International Journal of Antimicrobial Agents. 22(1). 77–80. 9 indexed citations

14.

Dandekar, Prachi K., Dana Maglio, Christina Sutherland, Charles H. Nightingale, & David P. Nicolau. (2003). Pharmacokinetics of Meropenem 0.5 and 2 g Every 8 Hours as a 3‐Hour Infusion. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 23(8). 988–991. 55 indexed citations

15.

Maglio, Dana, et al.. (2003). Pleconaril, a Novel Antipicornaviral Agent. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 23(3). 339–348. 42 indexed citations

16.

Maglio, Dana, David P. Nicolau, & Charles H. Nightingale. (2003). Impact of pharmacodynamics on dosing of macrolides, azalides, and ketolides. Infectious Disease Clinics of North America. 17(3). 563–577. 10 indexed citations

17.

Capitano, Blair, Dana Maglio, Mary Anné Banevicius, Charles H. Nightingale, & David P. Nicolau. (2003). Bactericidal effect of cethromycin (ABT-773) in an immunocompetent murine pneumococcal pneumonia model. International Journal of Antimicrobial Agents. 22(6). 588–593. 8 indexed citations

18.

Kuti, Joseph L., Dana Maglio, Charles H. Nightingale, & David P. Nicolau. (2003). Economic benefit of a meropenem dosage strategy based on pharmacodynamic concepts. American Journal of Health-System Pharmacy. 60(6). 565–568. 32 indexed citations

19.

Maglio, Dana, Renli Teng, Per T. Thyrum, Charles H. Nightingale, & David P. Nicolau. (2003). Pharmacokinetic Profile of Meropenem, Administered at 500 Milligrams Every 8 Hours, in Plasma and Cantharidin-Induced Skin Blister Fluid. Antimicrobial Agents and Chemotherapy. 47(5). 1771–1773. 19 indexed citations

20.

Maglio, Dana, Charles H. Nightingale, & David P. Nicolau. (2002). Extended interval aminoglycoside dosing: from concept to clinic. International Journal of Antimicrobial Agents. 19(4). 341–348. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact